Liver study tests drug safety for vulnerable patients
NCT ID NCT07049939
Summary
This study aimed to understand how a damaged liver processes an experimental drug called bomedemstat (MK-3543). Nine participants, some with mild or moderate liver problems and some healthy, took a single dose. Researchers tracked how much of the drug stayed in their blood over time to see if liver impairment changes how the body handles the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center ( Site 0001)
Orlando, Florida, 32809, United States
-
The Texas Liver Institute ( Site 0002)
San Antonio, Texas, 78215, United States
-
University of Miami ( Site 0003)
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.